Ablation vs Surgery Outcomes for Small RCC

• by Kathryn Wighton

• March 24, 2026

Neoadjuvant Chemo Did Not Improve Disease-Free Survival

Phase 3 NeoCol trial adds to mixed evidence as field shifts toward biomarker-guided approaches

• by Andrea Surnit

• May 1, 2026

• 5 min

Molecular Testing Improves Nodular Fasciitis Diagnosis

USP6 analysis helps resolve uncertainty in atypical soft-tissue lesions

• by Andrea Surnit

• April 3, 2026

• 3 min

Mandatory Training Modules Deserve a Harder Look

A JAMA Viewpoint argues that 4 million physician-hours spent on compliance modules each year warrants institutional reassessment.

• by Kerri Miller

• April 16, 2026

• 3 min